GFAP and Stroke: Additionally, prior validation of the LVOne GFAP LFA has been conducted in a stroke population against a commercial PoC platform (Abbott iSTAT TBI Plasma), demonstrating a similar degree of correlation to that observed in our study (Gaude et al. 2025).